    <SEC-DOCUMENT>0001129928-24-000056-index.html : 20240801
    <SEC-HEADER>0001129928-24-000056.hdr.sgml : 20240801
    <ACCEPTANCE-DATETIME>20240801165404
    ACCESSION NUMBER:		0001129928-24-000056
    CONFORMED SUBMISSION TYPE:	6-K
    PUBLIC DOCUMENT COUNT:		7
    CONFORMED PERIOD OF REPORT:	20240630
    FILED AS OF DATE:		20240801
    DATE AS OF CHANGE:		20240801

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			ONCOLYTICS BIOTECH INC
    		CENTRAL INDEX KEY:			0001129928
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		IRS NUMBER:				000000000
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		6-K
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-38512
    		FILM NUMBER:		241167569

    	BUSINESS ADDRESS:
    		STREET 1:		804, 322 - 11 AVENUE SW
    		CITY:			CALGARY
    		STATE:			A0
    		ZIP:			T2R 0C5
    		BUSINESS PHONE:		4036707380

    	MAIL ADDRESS:
    		STREET 1:		804, 322 - 11 AVENUE SW
    		CITY:			CALGARY
    		STATE:			A0
    		ZIP:			T2R 0C5
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>6-K
    <SEQUENCE>1
    <FILENAME>q22024form6-k.htm
    <DESCRIPTION>6-K
    <TEXT>
    Document 1 - file: q22024form6-k.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-99.1
    <SEQUENCE>2
    <FILENAME>ex991-interimfsjune302024.htm
    <DESCRIPTION>EX-99.1 2024 SECOND QUARTER INTERIM FINANCIAL STATEMENTS
    <TEXT>
    Document 2 - file: ex991-interimfsjune302024.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-99.2
    <SEQUENCE>3
    <FILENAME>ex992-q22024mda.htm
    <DESCRIPTION>EX-99.2 2024 SECOND QUARTER MD&A
    <TEXT>
    Document 3 - file: ex992-q22024mda.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-99.3
    <SEQUENCE>4
    <FILENAME>ex993-q22024certificationx.htm
    <DESCRIPTION>EX-99.3 Q2 2024 CERTIFICATION CEO
    <TEXT>
    Document 4 - file: ex993-q22024certificationx.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-99.4
    <SEQUENCE>5
    <FILENAME>ex994-q22024certificationx.htm
    <DESCRIPTION>EX-99.4 Q2 2024 CERTIFICATION CFO
    <TEXT>
    Document 5 - file: ex994-q22024certificationx.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>6
    <FILENAME>oncolyticslogotaglinebluea.jpg
    <TEXT>
    Document 6 - file: oncolyticslogotaglinebluea.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>7
    <FILENAME>oncolyticspipeline.jpg
    <TEXT>
    Document 7 - file: oncolyticspipeline.jpg

    </DOCUMENT>
    </SEC-DOCUMENT>